Submitted:
14 March 2024
Posted:
18 March 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Material and Methods
2.1. Study Design
2.2. Participant Selection
2.3. Data Collection
2.4. Human Resources
2.4.1. Radiographic Analysis
2.5. Statistical Analysis
3. Results
4. Discussion
4.1. Discussion of the Method
4.2. Discussion of the Results
5. Conclusion
Author Contributions
Funding
Institutional Review Board Statement
Conflicts of Interest
References
- Glick, M.; Williams, D.M.; Kleinman, D.V.; Vujicic, M.; Watt, R.G.; Weyant, R.J. A new definition for oral health developed by the FDI World Dental Federation opens the door to a universal definition of oral health. Br Dent J. 2016, 221, 792–793. [Google Scholar] [CrossRef]
- Baiju, R.M.; Peter, E.; Varghese, N.O.; Sivaram, R. Oral Health and Quality of Life: Current Concepts. J Clin Diagn Res. 2017, 11, ZE21–ZE26. [Google Scholar] [CrossRef] [PubMed]
- Hescot, P. The New Definition of Oral Health and Relationship between Oral Health and Quality of Life. Chin J Dent Res. 2017, 20, 189–192. [Google Scholar]
- Arrieta-Blanco, J.J.; Bartolome-Villar, B.; Jimenez-Martinez, E.; Saavedra-Vallejo, P.; Arrieta-Blanco, F.J. Bucco-dental problems in patients with Diabetes Mellitus (I): Index of plaque and dental caries. Med Oral. 2003, 8, 97–109. [Google Scholar] [PubMed]
- Scannapieco, F.A.; Cantos, A. Oral inflammation and infection, and chronic medical diseases: implications for the elderly. Periodontol 2000. 2016, 72, 153–175. [Google Scholar] [CrossRef] [PubMed]
- Cullinan, M.P.; Seymour, G.J. Periodontal disease and systemic illness: will the evidence ever be enough? Periodontol 2000. 2013, 62, 271–286. [Google Scholar] [CrossRef] [PubMed]
- Mauri-Obradors, E.; Estrugo-Devesa, A.; Jane-Salas, E.; Vinas, M.; Lopez-Lopez, J. Oral manifestations of Diabetes Mellitus. A systematic review. Med Oral Patol Oral Cir Bucal. 2017, 22, e586–e594. [Google Scholar] [CrossRef]
- Bartold, P.M. Oral health and systemic health - the great disconnect. Aust Dent J. 2012, 57, 403. [Google Scholar]
- Joshipura, K.J.; Munoz-Torres, F.J.; Dye, B.A.; Leroux, B.G.; Ramirez-Vick, M.; Perez, C.M. Longitudinal association between periodontitis and development of diabetes. Diabetes Res Clin Pract. 2018, 141, 284–293. [Google Scholar] [CrossRef]
- Teeuw, W.J.; Gerdes, V.E.; Loos, B.G. Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care. 2010, 33, 421–427. [Google Scholar] [CrossRef]
- Acharya, A.B.; Thakur, S.; Muddapur, M.V.; Kulkarni, R.D. Cytokine ratios in chronic periodontitis and type 2 diabetes mellitus. Diabetes Metab Syndr. 2017, 11, 277–278. [Google Scholar] [CrossRef]
- Sanz, M.; Lorenzo, R.; Aranda, J.J.; Martin, C.; Orsini, M. Clinical evaluation of a new collagen matrix (Mucograft prototype) to enhance the width of keratinized tissue in patients with fixed prosthetic restorations: a randomized prospective clinical trial. J Clin Periodontol. 2009, 36, 868–876. [Google Scholar] [CrossRef] [PubMed]
- Woodward, M.; Rumley, A.; Lowe, G.D.; Tunstall-Pedoe, H. C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 2003, 122, 135–141. [Google Scholar] [CrossRef]
- Sanz, M.; Marco Del Castillo, A.; Jepsen, S.; Gonzalez-Juanatey, J.R.; D’Aiuto, F.; Bouchard, P.; et al. Periodontitis and cardiovascular diseases: Consensus report. J Clin Periodontol. 2020, 47, 268–288. [Google Scholar] [CrossRef]
- Segura-Egea, J.J.; Jimenez-Pinzon, A.; Rios-Santos, J.V.; Velasco-Ortega, E.; Cisneros-Cabello, R.; Poyato-Ferrera, M. High prevalence of apical periodontitis amongst type 2 diabetic patients. Int Endod J. 2005, 38, 564–569. [Google Scholar] [CrossRef] [PubMed]
- Segura-Egea, J.J.; Castellanos-Cosano, L.; Machuca, G.; Lopez-Lopez, J.; Martin-Gonzalez, J.; Velasco-Ortega, E.; et al. Diabetes mellitus, periapical inflammation and endodontic treatment outcome. Med Oral Patol Oral Cir Bucal. 2012, 17, e356–e361. [Google Scholar] [CrossRef]
- Chen, L.; Wei, B.; Li, J.; Liu, F.; Xuan, D.; Xie, B.; et al. Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes. J Periodontol. 2010, 81, 364–371. [Google Scholar] [CrossRef]
- Stanko, P.; Izakovicova Holla, L. Bidirectional association between diabetes mellitus and inflammatory periodontal disease. A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014, 158, 35–38. [Google Scholar] [CrossRef] [PubMed]
- Lau, P.; Tran, A.; Chen, M.; Boyce, E.; Martin, R.; Calache, H. Interprofessional diabetes and oral health management: what do primary healthcare professionals think? F1000Res. 2021, 10, 339. [Google Scholar] [CrossRef] [PubMed]
- Han, S.J.; Yi, Y.J. The association between dyslipidemia, oral health behavior, and periodontal disease: The Korea National Health and Nutrition Examination Survey. Quintessence Int. 2019, 50, 394–401. [Google Scholar]
- Southerland, J.H. Periodontitis may contribute to poor control of hypertension in older adults. J Evid Based Dent Pract. 2013, 13, 125–127. [Google Scholar] [CrossRef]
- Tavares, M.; Lindefjeld Calabi, K.A.; San Martin, L. Systemic diseases and oral health. Dent Clin North Am. 2014, 58, 797–814. [Google Scholar] [CrossRef]
- Bolt, J.; Abdoulrezzak, R.; Inglis, C. Barriers and enablers to deprescribing of older adults and their caregivers: a systematic review and meta-synthesis. Eur Geriatr Med. 2023. [Google Scholar] [CrossRef] [PubMed]
- Wong, F.M.F.; Ng, Y.T.Y.; Leung, W.K. Oral Health and Its Associated Factors Among Older Institutionalized Residents-A Systematic Review. Int J Environ Res Public Health. 2019, 16. [Google Scholar] [CrossRef] [PubMed]
- Wei, N.J.; Wexler, D.J.; Nathan, D.M.; Grant, R.W. Intensification of diabetes medication and risk for 30-day readmission. Diabet Med. 2013, 30, e56–e62. [Google Scholar] [CrossRef] [PubMed]
- Torres, I.V.; Donlo, I.C. [Control of type 2 diabetes mellitus in Spain today: identification of the main obstacles in daily clinical practice]. Med Clin (Barc). 2013, 141 (Suppl. 2), 3–6. [Google Scholar] [CrossRef]
- Cheng, S.W.; Wang, C.Y.; Ko, Y. Costs and Length of Stay of Hospitalizations due to Diabetes-Related Complications. J Diabetes Res. 2019, 2019, 2363292. [Google Scholar] [CrossRef]
| P- value | |
|---|---|
| Smoking | 0.0007 * |
| Enolism | 0.7409 |
| Hypertension | 0.467 |
| Dyslipidemia | 0.8524 |
| Diabetes Mellitus type 2 | 0.663 |
| Diabetes Mellitus type 1 | 0.3912 |
| Control Glycemic | 0.5662 |
| Renal Insufficiency | 0.2825 |
| Cardiac Insufficiency | 0.8981 |
| Ischemic heart disease | 0.9445 |
| Chronic airflow obstruction | 0.4323 |
| Digestive disease | 0.906 |
| Infectious disease | 0.1706 |
| Cerebrovascular disease | 0.3912 |
| Cognitive impairment | 0.7262 |
| Chronic anemia | 0.3682 |
| Active neoplasm | 0.7723 |
| P- value | |
|---|---|
| Smoking | 0.0104 * |
| Enolism | 1 |
| Hypertension | 1 |
| Dyslipidemia | 0.5748 |
| Diabetes Mellitus type 2 | 0.5748 |
| Diabetes Mellitus type 1 | 0.2831 |
| Control Glycemic | 1 |
| Renal Insufficiency | 0.6889 |
| Cardiac Insufficiency | 1 |
| Ischemic heart disease | 1 |
| Chronic airflow obstruction | 1 |
| Digestive disease | 1 |
| Infectious disease | 0.1567 |
| Cerebrovascular disease | 1 |
| Cognitive impairment | 0.5361 |
| Chronic anemia | 0.6399 |
| Active neoplasm | 0.1715 |
| P- value | |
|---|---|
| Glucose | 0.1391 |
| Urea | 0.1081 |
| Creatinine | 0.298 |
| Uric acid | 0.4104 |
| Albumin | 0.3314 |
| Calcium | 0.5595 |
| Phosphorus | 0.4712 |
| Magnesium | 0.2293 |
| Sodium | 0.912 |
| Potassium | 0.0.030 * |
| Hierro | 0.8983 |
| Ferritin | 0.1514 |
| Transferrin | 0.3277 |
| Transferrin saturation | 0.5839 |
| Vitamin B12 | 0.2053 |
| C-reactive protein | 0.1868 |
| Procalcitonin | 0.2369 |
| Glomerular filtration | 0.1613 |
| Thyroid stimulating hormone | 0.2397 |
| HbA1c | 0.7981 |
| Vitamin D-0H25 | 0.0962 |
| Hemoglobin | 0.108 |
| Parathyroid hormone | 0.4036 |
| . | P- value |
|---|---|
| Glucose | 0.9216 |
| Urea | 0.9597 |
| Creatinine | 0.3372 |
| Uric acid | 0.8491 |
| Albumin | 0.3704 |
| Calcium | 0.5193 |
| Phosphorus | 0.9575 |
| Magnesium | 0.3259 |
| Sodium | 0.5985 |
| Potassium | 0.6502 |
| Hierro | 0.3123 |
| Ferritin | 0.4742 |
| Transferrin | 0.418 |
| Transferrin saturation | 0.7618 |
| Vitamin B12 | 0.5874 |
| C-reactive protein | 0.3612 |
| Procalcitonin | 0.9674 |
| Glomerular filtration | 0.3975 |
| Thyroid stimulating hormone | 0.0077 * |
| HbA1c | 0.2448 |
| Vitamin D-0H25 | 0.8065 |
| Hemoglobin | 0.1475 |
| Parathyroid hormone | 0.374 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).